97 related articles for article (PubMed ID: 28619427)
21. [Association between plasma levels of soluble leukocyte differentiation antigens CD₄₀/CD₄₀ ligand and kidney damage in preeclamptic patients].
Qin W; Zhan Y; Ye YH; Li C; Cui XN
Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):582-6. PubMed ID: 22169515
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of serum-soluble CD154 in fulminant hepatic failure.
Zheng YB; Gao ZL; Zhong F; Huang YS; Peng L; Lin BL; Chong YT
J Int Med Res; 2008; 36(4):728-33. PubMed ID: 18652769
[TBL] [Abstract][Full Text] [Related]
23. Serum level of interleukin 36 in patients with multiple sclerosis.
Alsahebfosoul F; Jahanbani-Ardakani H; Ghavimi R; Sedaghat N; Etemadifar M
J Immunoassay Immunochem; 2018; 39(5):558-564. PubMed ID: 30252593
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of CD40/CD40L system in rheumatic mitral stenosis with or without atrial fibrillation.
Azzam H; Abousamra NK; Wafa AA; Hafez MM; El-Gilany AH
Platelets; 2013; 24(7):516-20. PubMed ID: 22992131
[TBL] [Abstract][Full Text] [Related]
25. Activity profile in multiple sclerosis: an integrative approach. A preliminary report.
Zabaleta M; Marino R; Borges J; Camargo B; Ordaz P; De Sanctis JB; Bianco NE
Mult Scler; 2002 Aug; 8(4):343-9. PubMed ID: 12166506
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of the CD40-CD40 ligand system in pre-eclampsia.
Lukanov TH; Bojinova SI; Emin AL; Veleva GL; Popova VS; Konova EI
Int J Gynaecol Obstet; 2009 Jun; 105(3):257-60. PubMed ID: 19272596
[TBL] [Abstract][Full Text] [Related]
27. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein.
Guldiken S; Demir M; Arikan E; Turgut B; Azcan S; Gerenli M; Tugrul A
Thromb Res; 2007; 119(1):79-84. PubMed ID: 16476470
[TBL] [Abstract][Full Text] [Related]
28. Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.
Buchhave P; Janciauskiene S; Zetterberg H; Blennow K; Minthon L; Hansson O
Neurosci Lett; 2009 Jan; 450(1):56-9. PubMed ID: 18996438
[TBL] [Abstract][Full Text] [Related]
29. Platelet membrane CD154 and sCD154 in progressive peripheral arterial disease: a pilot study.
Young RS; Naseem KM; Pasupathy S; Ahilathirunayagam S; Chaparala RP; Homer-Vanniasinkam S
Atherosclerosis; 2007 Feb; 190(2):452-8. PubMed ID: 16777115
[TBL] [Abstract][Full Text] [Related]
30. Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients.
Gresle MM; Liu Y; Dagley LF; Haartsen J; Pearson F; Purcell AW; Laverick L; Petzold A; Lucas RM; Van der Walt A; Prime H; Morris DR; Taylor BV; ; Shaw G; Butzkueven H
J Neurol Neurosurg Psychiatry; 2014 Nov; 85(11):1209-13. PubMed ID: 24639436
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of CD40, its ligand CD40L and Bcl-2 in psoriatic patients.
Myśliwiec H; Flisiak I; Baran A; Górska M; Chodynicka B
Folia Histochem Cytobiol; 2012 Apr; 50(1):75-9. PubMed ID: 22532139
[TBL] [Abstract][Full Text] [Related]
32. Platelet - derived CD154 antigen in patients with chronic kidney disease.
Stępniewska J; Dołęgowska B; Chruściana M; Gołembiewska E; Malinowska-Jędraszczyk A; Marchelek-Myśliwiec M; Ciechanowski K
Clin Biochem; 2016 Feb; 49(3):243-7. PubMed ID: 26549757
[TBL] [Abstract][Full Text] [Related]
33. Imbalance in serum soluble CD30/CD30L and CD40/CD40L systems are associated with ovarian tumors.
Mielczarek-Palacz A; Sikora J; Kondera-Anasz Z; Hauza G
Hum Immunol; 2013 Jan; 74(1):70-4. PubMed ID: 23073297
[TBL] [Abstract][Full Text] [Related]
34. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of an ELISA for quantification of soluble IFN-β receptor: assessment in multiple sclerosis.
Órpez-Zafra T; Pavía J; Pinto-Medel MJ; Hurtado-Guerrero I; Rodriguez-Bada JL; Martín Montañez E; Fernández Ó; Leyva L; Oliver-Martos B
Bioanalysis; 2015; 7(22):2869-80. PubMed ID: 26571364
[TBL] [Abstract][Full Text] [Related]
36. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
[TBL] [Abstract][Full Text] [Related]
37. Serum soluble CD40L concentration depending on the stage of multiple myeloma and its correlation with selected angiogenic cytokines.
Kamińska J; Koper OM; Dymicka-Piekarska V; Motybel-Iwańczuk E; Ołdziej A; Kemona H
Pol Arch Med Wewn; 2016 May; 126(5):321-9. PubMed ID: 27243341
[TBL] [Abstract][Full Text] [Related]
38. High-mobility group box 1 in multiple sclerosis.
Sternberg Z; Sternberg D; Chichelli T; Drake A; Patel N; Kolb C; Chadha K; Yu J; Hojnacki D
Immunol Res; 2016 Apr; 64(2):385-91. PubMed ID: 26100980
[TBL] [Abstract][Full Text] [Related]
39. Increased circulating soluble CD40 levels in patients with slow coronary flow phenomenon: an observational study.
Durakoğlugil ME; Kocaman SA; Çetin M; Kirbaş A; Canga A; Erdoğan T; Çiçek Y
Anadolu Kardiyol Derg; 2013 Feb; 13(1):39-44. PubMed ID: 23070634
[TBL] [Abstract][Full Text] [Related]
40. Increased plasma-soluble CD40 concentration in patients with chronic urticaria with positive autologous serum skin test.
Jasinska T; Kasperska-Zajac A
Br J Dermatol; 2013 Jun; 168(6):1356-7. PubMed ID: 23517276
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
